Charles Wilson, MD
Otolaryngology · Ocean Springs, MSNPI 1558311431
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,812 of the $6,684 with a category attached, or 72.0%. It is spread thinly across 32 manufacturers, the largest accounting for just 20.1%. Reporting peaked in 2023 at $2,276 and has fallen 61.0% since, to $887 in 2025. Among otolaryngology clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $33.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$1K
- Medical Device Business Services, Inc.$1K
- Acclarent, Inc$620
- GSK$474
- CSL Behring$466
- Regeneron Healthcare Solutions, Inc.$461
- plus $2K from 26 others
What the payments were for
- Consulting fees$260%
- Travel & lodging$1,84628%
- Food & beverage$4,81272%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 10 | $1,341 |
| Medical Device Business Services, Inc. | 9 | $1,018 |
| Acclarent, Inc | 13 | $620 |
| GSK | 30 | $474 |
| CSL Behring | 21 | $466 |
| Regeneron Healthcare Solutions, Inc. | 20 | $461 |
| Sanofi | 14 | $360 |
| Novartis | 12 | $255 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $223 |
| Integra Lifesciences Corporation | 2 | $205 |
| Grifols USA, LLC | 8 | $163 |
| Amgen(2 entities) | 5 | $145 |
| Lilly USA, LLC | 1 | $100 |
| Genentech USA, Inc. | 4 | $99 |
| Pfizer | 5 | $90 |
| Ionis Pharmaceuticals, Inc. | 4 | $90 |
| Biocryst US Sales Co., LLC | 3 | $79 |
| Kaleo, Inc. | 4 | $74 |
| AbbVie | 3 | $67 |
| Merck | 3 | $50 |
| Boehringer Ingelheim | 3 | $50 |
| Optinose US, Inc. | 2 | $39 |
| Stryker | 2 | $36 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| ADMA Biomanufacturing LLC | 1 | $26 |
| Medtronic | 1 | $24 |
| Davol Inc. | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Incyte Corporation | 1 | $17 |
| Eyevance Pharmaceuticals LLC | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$986
- TruDi Nav Cable$226
- Acclarent Aera$112
- Inspira Air$112
- RELIEVA SPINPLUS NAV$112
- TruDi Probe$112
- Relieva Spinplus$105
- RETEVMO$100
How this compares
$6,684 in reported general payments places this provider in the 95th percentile of 97 otolaryngology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 80 | $2,754 |
| SynthroidLevothyroxine Sodium | 27 | $1,339 |
| Ofloxacin | 22 | $880 |
| Levothyroxine Sodium | 56 | $326 |
| Fluticasone Propionate | 23 | $301 |
| Cefdinir | 21 | $291 |
| Famotidine | 23 | $137 |
| Amoxicillin | 19 | $87 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $79 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $67 | $1,33927 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 97 otolaryngology providers in Mississippi.
Other otolaryngology in Ocean Springs
- Raymond WeissOcean Springs$258K
- Robert YarberTupelo$7K
- Gregory PippinMcComb$6K
- Savannah StocktonBrookhaven$6K
- John SchweinfurthJackson$6K
- Jess RobertsJackson$5K
- Byron WindhamOxford$5K
- Thomas EbyJackson$5K
- Anne KaneJackson$5K
- Gina JeffersonJackson$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.